Tag Archives: EXPLAINER: WHAT TO KNOW ABOUT COVID VACCINES FOR SMALL CHILDREN

Advisers to the U.S. Food and Drug Administration are due to meet this month to decide on whether to recommend authorizing Moderna’s vaccine for children below 6 years old, and Pfizer and BioNTech’s COVID-19 vaccine for children below 5 years old. Here is a look at some of the factors expected to be considered in this decision concerning the last …

Read More »